NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announces the addition of two distinguished experts to its Scientific Advisory Board.
NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announces the addition of two distinguished experts to its Scientific Advisory Board.